BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33407159)

  • 1. Overexpression of P-glycoprotein, MRP2, and CYP3A4 impairs intestinal absorption of octreotide in rats with portal hypertension.
    Sun X; Tang S; Hou B; Duan Z; Liu Z; Li Y; He S; Wang Q; Chang Q
    BMC Gastroenterol; 2021 Jan; 21(1):2. PubMed ID: 33407159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension.
    Sun XY; Duan ZJ; Liu Z; Tang SX; Li Y; He SC; Wang QM; Chang QY
    Exp Ther Med; 2016 Dec; 12(6):3716-3722. PubMed ID: 28105103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro and In Situ Characterization of the Intestinal Absorption of Capilliposide B and Capilliposide C from
    Zhang X; Cheng X; Wu Y; Feng D; Qian Y; Chen L; Yang B; Gu M
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30925820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.
    Patel M; Sheng Y; Mandava NK; Pal D; Mitra AK
    Int J Pharm; 2014 Dec; 476(1-2):99-107. PubMed ID: 25261710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
    Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
    Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S
    Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells.
    Fan J; Maeng HJ; Du Y; Kwan D; Pang KS
    Eur J Pharm Sci; 2011 Jan; 42(1-2):19-29. PubMed ID: 20955791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein.
    Liu Y; Liu B; Zhang Y; Peng Y; Huang C; Wang N; Jiang J; Wang Q; Chang J
    Eur J Pharm Sci; 2017 Jul; 105():150-158. PubMed ID: 28487144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
    Cummins CL; Mangravite LM; Benet LZ
    Pharm Res; 2001 Aug; 18(8):1102-9. PubMed ID: 11587480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.
    Liu Y; Wang Y; Peng Y; Liu B; Ma F; Jiang J; Wang Q; Chang J
    Pharmazie; 2018 Sep; 73(9):503-507. PubMed ID: 30223932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro.
    Zhao YY; Fan Y; Wang M; Wang J; Cheng JX; Zou JB; Zhang XF; Shi YJ; Guo DY
    Biomed Pharmacother; 2020 Dec; 132():110809. PubMed ID: 33049584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into drug absorption: studies with sirolimus.
    Paine MF; Leung LY; Watkins PB
    Ther Drug Monit; 2004 Oct; 26(5):463-7. PubMed ID: 15385826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the coordinated functional activities of cytochrome P450 3A4 and P-glycoprotein in limiting the absorption of xenobiotics in Caco-2 cells.
    Tran CD; Timmins P; Conway BR; Irwin WJ
    J Pharm Sci; 2002 Jan; 91(1):117-28. PubMed ID: 11782903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalin pharmacokinetic profile of absorption process using novel in-vitro model: cytochrome P450 3A4-induced Caco-2 cell monolayers combined with rat intestinal rinse fluids.
    Morisaki T; Hou XL; Takahashi K; Takahashi K
    J Pharm Pharmacol; 2013 Oct; 65(10):1526-35. PubMed ID: 24028620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in situ study on characterization and mechanism of the intestinal absorption of 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside.
    Wang C; Zhou Y; Gong X; Zheng L; Li Y
    BMC Pharmacol Toxicol; 2020 Jan; 21(1):7. PubMed ID: 31969193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.
    Giessmann T; May K; Modess C; Wegner D; Hecker U; Zschiesche M; Dazert P; Grube M; Schroeder E; Warzok R; Cascorbi I; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2004 Sep; 76(3):192-200. PubMed ID: 15371980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.
    van Waterschoot RA; ter Heine R; Wagenaar E; van der Kruijssen CM; Rooswinkel RW; Huitema AD; Beijnen JH; Schinkel AH
    Br J Pharmacol; 2010 Jul; 160(5):1224-33. PubMed ID: 20590614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine.
    Berggren S; Gall C; Wollnitz N; Ekelund M; Karlbom U; Hoogstraate J; Schrenk D; Lennernäs H
    Mol Pharm; 2007; 4(2):252-7. PubMed ID: 17263554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.